In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

Danielle Canioni¹, Jean-Marie Michot², Pascaline Rabiega³, Thierry J Molina¹, Frédéric Charlotte⁴, Thierry Lazure⁵, Frédéric Davi⁶, Catherine Settegrana⁶, Françoise Berger⁷, Laurent Alric⁸, Patrice Cacoub⁹, Benjamin Terrier⁹, Felipe Suarez^{10

11}, David Sibon^{10

11}, Jehan Dupuis¹², Cyrille Feray¹³, Hervé Tilly¹⁴, Stanislas Pol¹⁵, Bénédicte Deau Fischer¹⁶, Sandrine Roulland¹⁷, Catherine Thieblemont¹⁸, Véronique Leblond¹⁹, Fabrice Carrat³, Olivier Hermine^{10

11}, Caroline Besson²⁰; national ANRS HC13 LymphoC study

Affiliations

¹ Department of Pathology, Paris Descartes University, AP-HP, Sorbonne Paris Cité, Hôpital Necker, Paris, France.
² Department of Hematology and Drug Development, Gustave Roussy Institute, Villejuif, F-94805, France.
³ Institut Pierre Louis d'Epidémiologie et de Santé Publique INSERM UMR S1136, Paris 6 Pierre et Marie Curie University, Paris, France.
⁴ Department of Pathology, HôpitalPitié-Salpétrière, Paris 6 Pierre et Marie Curie University, Paris, France.
⁵ Department of Pathology, Paris 11 Sud University, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
⁶ Department of Biological Hematology, Paris 6 Pierre et Marie Curie University, AP-HP, Hôpital Pitié-Salpétrière, Paris, France.
⁷ Department of Pathology, Hopital Lyon Sud, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France.
⁸ Department of Internal Medicine and Digestive Diseases, Toulouse 3 University, UMR 152 IRD, Hôpital Purpan, Toulouse, France.
⁹ Department of Internal Medicine, APHP, Hôpital Pitié-Salpétrière, Paris 6 Pierre et Marie Curie University, UMR 7211, INSERM, UMR S 959, CNRS, Paris, France.
¹⁰ Department of Adult Hematology, Paris 5 Descartes University, AP-HP, Hôpital Necker, Paris, France.
¹¹ Imagine Institute, University Sorbonne Paris Cité, INSERM U 1163, CNRS ERL 8254, Paris, France.
¹² Department of Lymphoid Malignancies and Clinical Hematology, Paris 12 Est Créteil University, AP-HP, Hôpital Henri-Mondor, Créteil, France.
¹³ Department of Hepatology, Nantes University, Hôpital de Nantes, Nantes, France.
¹⁴ Department of Hematology, Rouen University, Centre Henri Becquerel, Rouen, France.
¹⁵ Department of Hepatology, Paris 5 Descartes University, INSERM U-1016, AP-HP, Hôpital Cochin, Paris, France.
¹⁶ Department of Hematology, Paris Descartes University, AP-HP, Hôpital Cochin, Paris, France.
¹⁷ Centre d'Immunologie de Marseille Luminy, Aix-Marseille Université INSERM U1104 CNRS UMR7280, Marseille, France.
¹⁸ Department of Hemato-oncology, University Paris Sorbonne P7, INSERM U728, AP-HP, Hôpital Saint-Louis, Paris, France.
¹⁹ Department of Clinical Hematology, Paris 6 Pierre et Marie Curie, Paris, France.
²⁰ Department of Internal Medicine & Clinical Immunology Biological Immunology and Hematology, Paris 11 Sud University, AP-HP, Hôpital Bicêtre, INSERM U 1184, Le Kremlin-Bicêtre, France.

PMID: 27257992
PMCID: PMC4892517
DOI: 10.1371/journal.pone.0156384

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

Danielle Canioni et al. PLoS One. 2016.

. 2016 Jun 3;11(6):e0156384.

doi: 10.1371/journal.pone.0156384. eCollection 2016.

Authors

Affiliations

¹ Department of Pathology, Paris Descartes University, AP-HP, Sorbonne Paris Cité, Hôpital Necker, Paris, France.
² Department of Hematology and Drug Development, Gustave Roussy Institute, Villejuif, F-94805, France.
³ Institut Pierre Louis d'Epidémiologie et de Santé Publique INSERM UMR S1136, Paris 6 Pierre et Marie Curie University, Paris, France.
⁴ Department of Pathology, HôpitalPitié-Salpétrière, Paris 6 Pierre et Marie Curie University, Paris, France.
⁵ Department of Pathology, Paris 11 Sud University, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
⁶ Department of Biological Hematology, Paris 6 Pierre et Marie Curie University, AP-HP, Hôpital Pitié-Salpétrière, Paris, France.
⁷ Department of Pathology, Hopital Lyon Sud, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France.
⁸ Department of Internal Medicine and Digestive Diseases, Toulouse 3 University, UMR 152 IRD, Hôpital Purpan, Toulouse, France.
⁹ Department of Internal Medicine, APHP, Hôpital Pitié-Salpétrière, Paris 6 Pierre et Marie Curie University, UMR 7211, INSERM, UMR S 959, CNRS, Paris, France.
¹⁰ Department of Adult Hematology, Paris 5 Descartes University, AP-HP, Hôpital Necker, Paris, France.
¹¹ Imagine Institute, University Sorbonne Paris Cité, INSERM U 1163, CNRS ERL 8254, Paris, France.
¹² Department of Lymphoid Malignancies and Clinical Hematology, Paris 12 Est Créteil University, AP-HP, Hôpital Henri-Mondor, Créteil, France.
¹³ Department of Hepatology, Nantes University, Hôpital de Nantes, Nantes, France.
¹⁴ Department of Hematology, Rouen University, Centre Henri Becquerel, Rouen, France.
¹⁵ Department of Hepatology, Paris 5 Descartes University, INSERM U-1016, AP-HP, Hôpital Cochin, Paris, France.
¹⁶ Department of Hematology, Paris Descartes University, AP-HP, Hôpital Cochin, Paris, France.
¹⁷ Centre d'Immunologie de Marseille Luminy, Aix-Marseille Université INSERM U1104 CNRS UMR7280, Marseille, France.
¹⁸ Department of Hemato-oncology, University Paris Sorbonne P7, INSERM U728, AP-HP, Hôpital Saint-Louis, Paris, France.
¹⁹ Department of Clinical Hematology, Paris 6 Pierre et Marie Curie, Paris, France.
²⁰ Department of Internal Medicine & Clinical Immunology Biological Immunology and Hematology, Paris 11 Sud University, AP-HP, Hôpital Bicêtre, INSERM U 1184, Le Kremlin-Bicêtre, France.

PMID: 27257992
PMCID: PMC4892517
DOI: 10.1371/journal.pone.0156384

Abstract

Hepatitis C Virus (HCV) infection is associated with the B-cell non-Hodgkin lymphomas (NHL), preferentially marginal zone lymphomas (MZL) and diffuse large B-cell lymphomas (DLBCL). While chronic antigenic stimulation is a main determinant of lymphomagenesis in marginal zone lymphomas (MZL), a putative role of HCV infection of B-cells is supported by in vitro studies. We performed a pathological study within the "ANRS HC-13 LymphoC" observational study focusing on in situ expression of the oncogenic HCV non structural 3 (NS3) protein. Lympho-C study enrolled 116 HCV-positive patients with B-NHL of which 86 histological samples were collected for centralized review. Main histological subtypes were DLBCL (36%) and MZL (34%). Almost half of DLBCL (12/26) were transformed from underlying small B-cell lymphomas. NS3 immunostaining was found positive in 17 of 37 tested samples (46%). There was a striking association between NS3 detection and presence of high grade lymphoma features: 12 out of 14 DLBCL were NS3+ compared to only 4 out of 14 MZL (p = 0.006). Moreover, 2 among the 4 NS3+ MZL were enriched in large cells. Remarkably, this study supports a new mechanism of transformation with a direct oncogenic role of HCV proteins in the occurrence of high-grade B lymphomas.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

**Fig 1. NS3 immunostaining in HCV associated non-Hodgkin’s lymphomas.**
A: Negative staining of a marginal zone lymphoma (MZL). B: Strong staining of a Diffuse Large B-Cell Lymphoma. C: Weak staining of a “classical” MZL. D: Strong staining of a MZL enriched in large cells.

**Fig 2. NS3 immunostaining in controls.**
A: Negative staining in a DLBCL biopsy from a HCV negative patient. B: Strong positive staining in a liver biopsy from a HCV positive patient without lymphoma.

See this image and copyright information in PMC

References

1. Engels EA, Chatterjee N, Cerhan JR, Davis S, Cozen W, Severson RK et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer. 2004;111:76–80. - PubMed
1. Nieters A, Kallinowski B, Brennan P, Ott M, Maynadié M, Benavente Y, et al. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology. 2006;131:1879–86. - PubMed
1. Michot J-M, Canioni D, Driss H, Alric L, Cacoub P, Suarez F, Sibon D, et al. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study. Am J Hematol. 2015;90:197–203. 10.1002/ajh.23889 - DOI - PubMed
1. Besson C, Canioni D, Lepage E, Pol S, Morel P, Lederlin P,et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d’Etude des Lymphomes de l’Adulte programs. J Clin Oncol. 2006; 24:953–60. - PubMed
1. Arcaini L, Paulli M, Boveri E, Vallisa D, Bernuzzi P, Orlandi E,et al. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer. 2004;100:107–15. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

Affiliations

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical